3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Prostatic Neoplasms
5
Carcinoma, Non-Small-Cell Lung
3
Urinary Bladder Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Radiation Injuries
1
Neoplasm Metastasis
1
Nasopharyngeal Carcinoma
1
Mouth Neoplasms
1
Meningioma
1
Glioblastoma
1
Frailty
1
Esophageal Neoplasms
1
Carcinoma, Hepatocellular
1
Breast Neoplasms
1
Anatomic Stage IV Breast Cancer AJCC v8
1
Advanced Lung Neuroendocrine Tumor
1
Interventions
Radiotherapy
12
Amifostine
7
Cisplatin
6
Etoposide
3
Carboplatin
3
Bevacizumab
3
Radiotherapy, Intensity-Modulated
2
Radiation
2
Paclitaxel
2
Heavy Ion Radiotherapy
2
Fluorouracil
2
sargramostim
1
lithium sulfate
1
Vincristine
1
Surgical Procedures, Operative
1
Steroids
1
Selenomethionine
1
Rituximab
1
Protons
1
Proton Therapy
1
Procarbazine
1
Physical Therapy Modalities
1
Photons
1
Palonosetron
1
Olanzapine
1
Methylprednisolone
1
Methotrexate
1
Mental Status and Dementia Tests
1
Melatonin
1
Magnetic Resonance Spectroscopy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Radiation Injuries
×
Photons
×
Clear all
NCT05548504
2022-09-21
HERAN2
Odense University Hospital
Phase 2
Not yet recruiting
182 enrolled